TruSpine Technolgs. - Shareholder Requisition Notice
Announcement provided by
TruSpine Technologies Plc · TSP26/04/2023 10:35
26 April 2023
TruSpine Technologies plc
("TruSpine" or the "Company")
Shareholder Requisition Notice
TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received an email dated 14 April 2023 from Janice Stone, Peter Houghton, Todd Michael Cramer and Christopher Blank (together the "Named Shareholders"), who hold in excess of 5 per cent. of the issued share capital of the Company, requiring that the Company convene, as soon as reasonably practicable, a general meeting ("Requisition").
The board changes proposed by the Named Shareholders are:
i. that Norman Lott be removed as a director and company secretary of the Company;
ii. that Nikunj Patel be removed as a director of the Company;
iii. that Annabel Schild be removed as a director of the Company;
iv. that Laurence Strauss be removed as a director of the Company;
v. that Todd Michael Cramer be appointed as a director of the Company;
vi. that Peter Houghton be appointed as a director of the Company;
vii. that Anthony Swoboda be appointed a director of the Company; and
viii. that the adjourned 2022 annual general meeting be re-convened as soon as reasonably practical.
The letter is a requisition by the Named Shareholders under section 303 of the Companies Act 2006.
The Company is mindful that, pursuant to section 304 of the Companies Act 2006, the Company must post a notice convening a general meeting within 21 days from the date on which the requisition was received, and this meeting must be held on a date not more than 28 days after the date of the notice to shareholders convening the general meeting.
A further announcement will be made regarding a general meeting in due course.
This announcement contains inside information for the purposes of the
Enquiries:
TruSpine Technologies Plc |
Tel: +44 (0)20 3638 5025 |
Laurence Strauss, Chief Executive Officer |
|
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
Tel: +44 (0)20 7213 0880 |
Liam Murray / Ludovico Lazzaretti |
|
Oberon Capital (Joint Broker) |
|
Mike Seabrook / Chris Crawford
|
|
Peterhouse Capital Limited (Joint Broker & Financial Adviser) |
|
Lucy Williams / Duncan Vasey
|
|
Novus Communications (PR and IR) |
Tel: +44 (0)207 448 9839 |
Alan Green / Jacqueline Briscoe |
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.